Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Riedel

Showing results (181-190 of 219) with videos related to

Pageof 22
Sort By:
The Oncologist|December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal TumorsCissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
JCO Precision Oncology|July 2, 2025
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in ChordomaDaniel S Lefler, Andrew Elliott, Wei Jiang, et al.
Cancer Medicine|August 11, 2022
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial resultsSteven Attia, Vanessa Bolejack, Kristen N Ganjoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell TumorsAndrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2026
Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 CasesCésar Serrano, Andrew Elliott, David Gómez-Peregrina, et al.
Cancer|August 25, 2024
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor BoardAjay Gupta, Matthew S Dietz, Richard F Riedel, et al.
Future Oncology (London, England)|April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcomaMrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Future Oncology (London, England)|December 22, 2025
A plain language summary of the AMPECT study: nab-sirolimus for advanced malignant perivascular epithelioid cell tumorsAndrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
The Oncologist|March 25, 2018
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced CancerGordana Vlahovic, Kellen L Meadows, Ace J Hatch, et al.
Journal of Adolescent and Young Adult Oncology|February 1, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working GroupSusan L Whiteway, Aaron R Weiss, Safia K Ahmed, et al.
Pageof 22

Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
The Oncologist|December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal TumorsCissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
JCO Precision Oncology|July 2, 2025
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in ChordomaDaniel S Lefler, Andrew Elliott, Wei Jiang, et al.
Cancer Medicine|August 11, 2022
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial resultsSteven Attia, Vanessa Bolejack, Kristen N Ganjoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell TumorsAndrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2026
Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 CasesCésar Serrano, Andrew Elliott, David Gómez-Peregrina, et al.
Cancer|August 25, 2024
Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor BoardAjay Gupta, Matthew S Dietz, Richard F Riedel, et al.
Future Oncology (London, England)|April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcomaMrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Future Oncology (London, England)|December 22, 2025
A plain language summary of the AMPECT study: nab-sirolimus for advanced malignant perivascular epithelioid cell tumorsAndrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
The Oncologist|March 25, 2018
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced CancerGordana Vlahovic, Kellen L Meadows, Ace J Hatch, et al.
Journal of Adolescent and Young Adult Oncology|February 1, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working GroupSusan L Whiteway, Aaron R Weiss, Safia K Ahmed, et al.
Pageof 22